Florian Lordick Elected ESMO President 2029–2030

oncodaily - Professor Florian Lordick has been elected President of the European Society for Medical Oncology for the 2029–2030 term, marking a new leadership chapter for one of the world’s leading oncology […]

AI Summary: Florian Lordick will serve as ESMO president for 2029–2030, pledging to prioritise precision oncology, workforce development and stronger European collaboration. Colleagues praise his vision for translating research into practice and amplifying policy advocacy; expectations include initiatives to close care gaps and bolster international partnerships — because someone has to herd this many oncologists.

#healthcare #publichealth #governmentpolicy #oncology #cancerresearch #researchfunding #clinicaltrials #healthdisparities

21 days / oncodaily

21 days / oncodaily

21 days / oncodaily

5 wks / oncodaily

5 wks / esmo


Back to Top / Sun, June 7, 2026, 10:21 pm / permalink 24959 / 5 stories in 4 wks /




Related Stories


American Cancer Society releases global cancer statistics showing rising burden / 2 days

AACR issues major cancer disparities and health-equity progress report / 15 days

AACR names 2026 Distinguished Service Award recipients / 2 months

Introducing ISCO 2026 chairs and program highlights / 2 months

Population lung screening lowers deaths in never‑smokers / 3 months

Studies neglect women's experiences in childbirth and breastfeeding research / 1 month

American Cancer Society launches pediatric and AYA cancer journal / 3 months

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Animal Health, Price Transparency, Medical Devices, Government Policy and look for the RSS link.





NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.